Scholarly Index
Theo Rispens
Sanquin; 17,746 total citations; 385 total publications; best world rank #55
Sanquin
17,746Total citations
385Total publications
68H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 559 | NL 20 | 99.04 |
| Glycosylation and Glycoproteins Research | Lifetime | 606 | NL 20 | 98.17 |
| Biosimilars and Bioanalytical Methods | Lifetime | 111 | NL 11 | 97.74 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 616 | NL 19 | 97.51 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 137 | NL 2 | 95.43 |
| Galectins and Cancer Biology | Lifetime | 546 | NL 23 | 95.19 |
| Protein purification and stability | Lifetime | 474 | NL 15 | 95.85 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 55 | NL 6 | 98.60 |
| T-cell and B-cell Immunology | 2021-2025 | 249 | NL 7 | 93.28 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 530 | NL 22 | 88.62 |
| Glycosylation and Glycoproteins Research | 2021-2025 | 698 | NL 41 | 84.11 |
| Complement system in diseases | 2021-2025 | 507 | NL 33 | 79.07 |
| Platelet Disorders and Treatments | 2021-2025 | 915 | NL 56 | 79.45 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 843 | NL 12 | 78.57 |
| Polyomavirus and related diseases | 2021-2025 | 680 | NL 10 | 76.03 |